-
Fast Company Honors Braeburn Pharmaceuticals as a Top Ten Most Innovative Company in Biotech
Post on 2/13/17
-
NanoViricides Reports the Company's Director Dr. Boniuk Converted Series B Debenture to Equity Effectively Raising $5M in New Equity for the Company
Post on 2/13/17
-
3 Beaten-Down Stocks Ready to Bounce Back
Post on 2/13/17
-
Will Seattle Genetics' Deal With Immunomedics Get Scuttled?
Post on 2/13/17
-
3 Reasons Johnson & Johnson's Actelion Deal Might Not Be Totally Crazy
Post on 2/13/17
-
Immunomedics Enters into Global Licensing Agreement with Seattle Genetics
Post on 2/12/17
-
Bristol-Myers Squibb: Much Ado About (Almost) Nothing
Post on 2/10/17
-
Ovid Therapeutics and NeuroPointDX Announce Collaboration
Post on 2/9/17
-
Interpace Diagnostics Closes $3.9 Million Public Offering
Post on 2/8/17
-
Better Buy: Merck & Co. Inc. vs. GlaxoSmithKline
Post on 2/8/17
-
Better Buy: Kimberly-Clark Corporation vs. Johnson & Johnson
Post on 2/8/17
-
Q Biomed Joins with Oklahoma Medical Research Foundation And Rajiv Gandhi Centre For Biotechnology
Post on 2/7/17
-
These 2 Factors Sent Bristol-Myers Squibb Co. Tumbling by 16% in January
Post on 2/7/17
-
Pfizer May Be Another IBM
Post on 2/6/17
-
Pfizer's New Biosimilar Is Off and Running
Post on 2/6/17
-
Palatin Technologies Closes License Agreement with AMAG Pharmaceuticals
Post on 2/5/17
-
Interpace Diagnostics Prices Public Offering to Raise $3.6 Million
Post on 2/5/17
-
Seatrade Cruise Global 2017 Names Mercy Ships As Non-Profit Partner
Post on 2/5/17
-
Pernix Therapeutics Provides Update on Arbitration
Post on 2/3/17
-
Interpace Diagnostics Proposes Public Offering of Common Stock
Post on 2/2/17
-
Ambra Health Named #1 Medical Image Exchange Vendor by KLAS For Third Year in a Row
Post on 2/2/17
-
Carestream Health Partners with Zebra Medical Vision
Post on 2/2/17
-
Nestlé to Expand Manufacturing Capacity at Eau Claire Plant
Post on 2/2/17
-
5 Things Pfizer's Management Wants You to Know
Post on 2/2/17
-
3 Pharmaceutical Stocks With Bigger Dividends Than Johnson & Johnson
Post on 2/2/17
New York
